(Although the content is expressed in ng/ml, the volume of rabbit seminal plasma seldom exceeds 0.5ml.) Table 1 shows that the seminal plasma of these six mammalian species contains very little or no detectable prostaglandin, especially prostaglandins of the F series. The pig, horse, dog and rat are uterine depositors of semen, whereas the bull and rabbit, together with the sheep and human are vaginal depositors. It is evident that there is no correlation between site of deposition and prostaglandin content of semen.
However, this does not necessarily mean that PGF2. in sheep and human semen is not important for the penetration of sperm through cervical mucus.
Prostaglandins have been implicated more generally in sperm movement. PGEi does hasten the transport of sperm from the vagina to the oviduct in rabbits (Mandl, 1972) . However, the PGE content of rabbit semen is well below the threshold dose for this effect. It would appear from the present results that, in the majority ofanimals examined, the presence of prostaglandins in their semen is not essential for the normal transport of sperm. Similarly, it has been postulated that prostaglandins aid ejaculation in the male owing to their smooth-muscle-contracting activity. However, animals that have very little or no detectable prostaglandin in their semen obviously have no difficulty in ejaculation. Also human subjects receiving high doses of aspirin had no difficulty in ejaculating even though their seminal plasma PGE concentrations were some 80% below normal (Horton et a[., 1973) . Consequently it is doubtful whether prostaglandins are essential for normal ejaculation to occur, especially as an inhibitor of the smoothmuscle-contracting activity of prostaglandins has been demonstrated in sheep and human semen (Dineen et al., 1974) .
Also, there is no relation between prostaglandin concentration and degree of motility of spermatozoa in the human ejaculate (Asplund, 1947; Bygdeman & Samuelsson, 1966) . Further, prostaglandin has no effect on the O2 consumption of washed human spermatozoa, whereas PGEl has no direct effect on motility, O2 uptake and fructose and lactic acid metabolism (Horton, 1965; Eliasson et al., 1968) . Consequently, it is difficult to assign a specific role to any seminal plasma prostaglandin in the fertilization process, especially as some animals apparently carry out this procedure with very little or no prostaglandin in their semen. However, Bygdemanetal. (1970) didfindacorrelation between low seminal plasma PGE concentrations and infertility in men.
Turning to the female, there is strong evidence that prostaglandins are involved in at least two physiological processes, namely luteolysis and ovulation. As regards luteolysis, it appears that PGFza released from the uterus into the venous drainage of the sheep (Bland etal., 1971 ; McCracken etal., 1972; Thorburn et al., 1972) , guinea pig (Blatchley, et al., 1972) , pig (Gleeson & Thorburn, 1973) and cow (Nancarrow et al., 1973) causes regression of the corpora lutea and thereby terminates the luteal phase of the cycle. It has been found that by raising antibodies to PGF,. in sheep (Scaramuzzi et al., 1973) and guinea pig , oestrous-cycle length is considerably increased. These results provide further evidence that prostaglandins of the F series are involved in the control of the normal oestrous cycle. Further, receptors for PGF2. have now been found in ovine (Powell et al., 1974a ) and bovine (see Powell et al., 19746 ) corpora lutea.
Attention has also been focused on determining the physiological stimulus for the output of prostaglandins from the uterus. Blatchley et al. (1971 Blatchley et al. ( , 1972 showed that oestradiol caused the release of PGF2. from the guinea-pig uterus. Consequently, they postulated that oestradiol released from the growing follicles may possibly form the physiological stimulus. Evidence supporting this hypothesis has come from the measurement of the concentrations of oestrogens in guinea-pig ovarian venous blood (Joshi et al., 1973) . The concentrations of oestradiol increase on days 11 and 15 of the cycle, the times at which PGF,, concentrations in utero-ovarian venous blood also increase (Blatchley et al., 1972) , suggesting a cause and effect relationship. However, the importance of progesterone cannot be overlooked. In ovariectomized sheep, progesterone pretreatment of the uterus is necessary for this effect of oestradiol to be seen Scaramuzzi et al., 1974) . The same conclusion has been reached in the ovariectomized guinea pig . Also, PGF2, concentrations in uterine tissue of ovariectomized mice are highest after treatment with both progesterone and oestradiol (Saksena & Lau, 1973) . Thus it appears that oestradiol and progesterone together form the physiological stimulus for PGF,, output from the uterus.
Although it is now clear that PGFz. released from the uterus of some mammals terminates the life-span of the corpora lutea and thereby regulates oestrous-cycle length, pregnancy in some way must interrupt this mechanism since the corpora lutea in the pregnant animal are spared from this demise. Recently, we have been able to show that the pregnant guinea-pig uterus on day 15 produces six times less PGF,, than the non-pregnant uterus at day 15 when both are homogenized and incubated in vitro (Maule Walker & Poyser, 1973 ,1974 . This difference is reflected in the PGF,, concentrations in the utero-ovarian venous blood, since the amounts in the pregnant animal at this time are much lower than in the non-pregnant animal. Accordingly progesterone concentrations are higher in the pregnant animal, whereas oestradiol amounts are appreciably lower (Blatchley et al., 1974) . Analysis of uterine venous blood of pregnant and non-pregnant sheep produced similar findings (Thorburn et al., 1973 ). It appears from the results that the conceptus decreases PGF,, production by, and output from, the uterus, probably by releasing an anti-luteolytic hormone, which acts, at least in part, by decreasing oestradiol output from the ovary.
Little attention has been paid so far to the woman. It is well established that the human uterus does not control the life-span of the corpus luteum. Notwithstanding, there is a significant rise in the amount of PGF,, in the endometrium during the luteal phase of the cycle (when oestrogen and progesterone concentrations are together at their highest), and this concentration is maintained up to menstruation. PGE, concentrations also rise significantly at menstruation (Downie et al., 1974) . It is probable that the endometrial prostaglandins are involved in the menstrual process, though a precise
role has yet to be established. Although human uterine prostaglandins are not involved in regression of the corpus luteum, many authors have suggested that perhaps PGF,. generated in the ovary itself brings about luteal regression. Receptors for PGF2. are in fact present in the human corpus luteum (Powell et al., 19746) . Corpora lutea from rats are able to produce PGF,. when cultured in vitro (Demers et al., 1973) , and it is possible that PGF,. generated by the human corpus luteum may lead to its own regression. A human corpus luteum (of unspecified time in the cycle) has been analysed in this laboratory, but PGF,. was not detectable in it (<50ng/g) (J. Downie & N. L. Poyser, unpublished work) . However, prostaglandin concentrations are usually very low in tissues, so this result does not necessarily mean that the human corpus luteum cannot produce PGF,. at the time of luteal regression. It is equally possible, though, that PGF2. produced outside the corpus luteum in other structures of the ovary may be responsible for luteal regression. One problem in suggesting that ovarian PGF,, is responsible for luteal regression is that, unlike in other animals, the systemic administration of PGF,, to women does not cause luteal regression. Powell et al. (19746) have suggested that PGF,, synthesized locally in the ovary makes the human corpus luteum less susceptible to exogenous PGF,, than the corpora lutea of other species, which are supplied with PGF,, from the uterus. The way in which this is achieved is not stated. Also they suggest that the rapid metabolism of PGF,. in women potentiates this effect when the luteolytic action of PGF,. is studied. However, it is still difficult to understand why the systemic administration of PGF,. should have a pharmacological effect on the uterus without having a physiological effect on the ovary. Nonetheless, it is clear that the humamcorpus luteum seems particularly resistant to the luteolytic action of administered PGF,.. The critical experiment of measuring progesterone amounts after the local administration of PGF,, via the ovarian artery has not been carried out owing to obvious technical and ethical reasons. PGF,. in vitro did inhibit the synthesis de nouo of progesterone by human corpora lutea of pregnancy (Archer & Petrelli, 1973) . Also PGF2, in uitro decreased the rate of progesterone synthesis by a corpus luteum of pregnancy obtained from a woman who had been pretreated extra-amniotically with PGF,, for 30h. These results indicate that PGF,, can have a luteolytic effect on human corpora lutea. However, despite all these observations and suggestions it is still open to question whether PGF2. is involved in the normal regression of the human corpus luteum. It is still not clear whether anything other than the withdrawal of pituitary support for the corpus luteum is required anyway.
Turning to the second process in which prostaglandins are involved, namely ovulation, this involvement became apparent when ovulation was blocked in rats and rabbits after indomethacin treatment (Orczyk & Behrman, 1972; ; Grinwich et al., 1972; O'Grady et al., 1972) . Recently, the amounts of PGF and PGE have been determined in rabbit graafian follicles, and both increase significantly after an ovulatory dose of human chorionic gonadotrophin or luteinizing hormone, and after mating, up to the time of ovulation (LeMaire et al., 1973; Armstrong el al., 1974) . These increases were blocked if the rabbits were pretreated with indomethacin . Also, in those follicles where ovulation fails to take place, prostaglandin concentrations are much lower than the concentrations found in those follicles that ovulated (Yang et al., 1974) . Further, ovulation in rabbits was blocked after the intrafollicular injection of indomethacin or antiserum raised to PGF2., (Armstrong et al., 1974) .
Antiserum raised to PGE2 was less effective in this blocking action. It is evident that prostaglandins produced in the ovary are involved in the ovulatory process. In rabbits PGF2. seems the more important one involved. In rats, however, PGFza was ineffective in overcoming ovulation blockade by indomethacin, whereas PGEz was much more effective (Tsafriri et al., 1972) . Thus it is not clear which prostaglandin is essentially involved in ovulation. Obviously species difference may account for the difference in the results obtained. Also a mixture of prostaglandins acting together in the ovulatory process cannot be ruled out.
A mechanism by which the ovulatory PGEz is generated has recently been proposed (Poyser, 1973; Kuehl, 1974) . This involves cleavage of arachidonic acid from the cholesterol esters involved in progesterone synthesis, and the conversion of the arachidonic acid into PGE2, under the influence of luteinizing hormone. (PGF2, could easily be generated in the same way if involved in ovulation.) Luteinizing hormone has been shown to stimulate PGEz production by rat ovaries in uitro (Chasalow & Pharriss, 1972) , and PGF2. by rat corporalutea also in tiitro (Demers et ul., 1973) . Whether prostaglandins are involved in ovulation in other species of mammal, including women, has yet to be established.
